Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HBB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR7E14P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MCTP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RETN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AXIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC9-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf135-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506679 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on